Angelo A Petropolis, MD | |
1916 Paseo San Luis, Sierra Vista, AZ 85635 | |
(520) 458-1505 | |
(520) 458-6949 |
Full Name | Angelo A Petropolis |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 39 Years |
Location | 1916 Paseo San Luis, Sierra Vista, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457391732 | NPI | - | NPPES |
AZ0776240 | Other | BCBS AZ | |
325242 | Medicaid | AZ | |
516118 | Other | AZ | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 22192 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Epiphany Dermatology Of Arizona Llc | 9830181361 | 25 |
News Archive
Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.
› Verified 5 days ago
Entity Name | Epiphany Dermatology Of Arizona Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457465858 PECOS PAC ID: 9830181361 Enrollment ID: O20040402000307 |
News Archive
Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Angelo A Petropolis, MD 7300 Ranch Road 2222, Building 1, Ste 200, Austin, TX 78730 Ph: (512) 628-0465 | Angelo A Petropolis, MD 1916 Paseo San Luis, Sierra Vista, AZ 85635 Ph: (520) 458-1505 |
News Archive
Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.
Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising.
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology.
› Verified 5 days ago
Matthew Crosby, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1916 Paseo San Luis, Sierra Vista, AZ 85635 Phone: 520-458-1505 | |
Dr. Richard Helge Weyer, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 165 El Camino Real, Sierra Vista, AZ 85635 Phone: 520-458-1787 Fax: 520-458-1519 | |
Dr. Christopher William Weyer, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 S Coronado Dr Ste 110, Sierra Vista, AZ 85635 Phone: 520-458-1787 Fax: 520-458-1519 |